Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
CISPLATIN
HIKMA CANADA LIMITED
L01XA01
CISPLATIN
1MG
SOLUTION
CISPLATIN 1MG
INTRAVENOUS
15G/50G
Prescription
Active ingredient group (AIG) number: 0113245002; AHFS:
APPROVED
2023-03-17
PRODUCT MONOGRAPH PR CISPLATIN INJECTION BP Sterile solution 1 mg / mL (50 mg and 100 mg cisplatin per vial) THERAPEUTIC CLASSIFICATION Antineoplastic Agent Hikma Canada Limited 5995 Avebury Road, Suite 804 Mississauga, Ontario L5R 3P9 Date of Preparation: March 16, 2023 Submission Control No.: 263374 _Pr_ _Cisplatin Injection BP Product Monograph _ _Page 2 of 20 _ PRODUCT MONOGRAPH PR CISPLATIN INJECTION BP Sterile solution 1 mg / mL THERAPEUTIC CLASSIFICATION Antineoplastic Agent CAUTION CISPLATIN INJECTION BP IS A POTENT DRUG AND SHOULD BE USED ONLY BY PHYSICIANS EXPERIENCED WITH CANCER CHEMOTHERAPEUTIC DRUGS (SEE WARNINGS AND PRECAUTIONS). BLOOD COUNTS AS WELL AS RENAL AND HEPATIC FUNCTION TESTS SHOULD BE TAKEN REGULARLY. DISCONTINUE THE DRUG IF ABNORMAL DEPRESSION OF BONE MARROW OR ABNORMAL RENAL OR HEPATIC FUNCTION IS SEEN. ACTION AND CLINICAL PHARMACOLOGY Cisplatin has biochemical properties similar to those of bifunctional alkylating agents producing inter-strand and intra-strand cross-links in DNA. It is apparently not cell-cycle specific. PHARMACOKINETICS Following bolus injection, or intravenous infusion over 2 to 7 hours, of doses ranging from 50 to 100 mg/m 2 , plasma cisplatin half-life is approximately 30 minutes. The ratios of cisplatin to total, free (ultrafilterable) platinum in the plasma range from 0.4 to 1.1 after a dose of 100 mg/m 2 . Cisplatin does not undergo instantaneous and reversible binding to plasma proteins characteristic of normal drug-protein binding. However, the platinum from cisplatin becomes bound to plasma proteins. These complexes are slowly eliminated with a half-life of 5 days or more. Following cisplatin doses of 20 to 120 mg/m 2 , the concentrations of platinum are highest in liver, prostate and kidney, somewhat lower in bladder, muscle, testicle, pancreas and spleen and lowest in bowel, adrenal, heart, lung, cerebrum and cerebellum. Platinum is present in tissues for as long as 180 days after the last administration. With the exception of intracerebral tumors, platinum Baca dokumen lengkap